| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b08331191edf52b8907dd1b18d355982 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 |
| filingDate |
2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07d56dfa6890cd0651813668ecdaab69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae7626db49ee356b492e870cfbc1941e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca6a25fb910f7cb1bfbbbc774f74e40c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4d40dd8f3a5e1b552c2557580b24917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c996e880b862ef155c765da25a091909
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c99f50c6f559c4a26226ea98a877bee3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88bfc4cfd96c79ca8ec83abbf500ed47 |
| publicationDate |
2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10376525-B2 |
| titleOfInvention |
Treprostinil administration by inhalation |
| abstract |
Treprostinil can be administered using a metered dose inhaler. Such administration provides a greater degree of autonomy to patients. Also disclosed are kits that include a metered dose inhaler containing a pharmaceutical formulation containing treprostinil. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020171044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11660304-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022108939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023154705-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712442-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744835-B2 |
| priorityDate |
2006-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |